ICD G37.3ORPHA:139417TM

Transverse Myelitis

Transverse Myelitis is an inflammatory condition affecting the spinal cord that disrupts the nerve signals running through it, causing weakness, sensory disturbances, and bladder or bowel dysfunction. It can be idiopathic or a manifestation of NMOSD, MS, or other autoimmune diseases. Recovery varies widely from complete to significant permanent disability.

341
Articles
17
Trials
Updated
5 April 2026
Loading...

Common Questions

What is Transverse Myelitis?

Transverse Myelitis is an inflammatory condition affecting the spinal cord that disrupts the nerve signals running through it, causing weakness, sensory disturbances, and bladder or bowel dysfunction. It can be idiopathic or a manifestation of NMOSD, MS, or other autoimmune diseases. Recovery varies widely from complete to significant permanent disability.

How many clinical trials are available for Transverse Myelitis?

RareWays currently indexes 17 clinical trials for Transverse Myelitis, of which 3 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Transverse Myelitis come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Transverse Myelitis.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.